Profil
Orville G.
Kolterman is currently a Director at the American Diabetes Association Research Foundation, Inc., GlySens, Inc., and a Member at the National Institute of Diabetes & Digestive & Kidney Diseases.
He was previously a Director at ViaCyte, Inc., the Medical Director-Diabetes Center at the University of California San Diego, Chief Medical Officer & Senior Vice President at Amylin Pharmaceuticals, Inc., and President at the American Diabetes Association.
He was also an Assistant Professor at The University of Colorado School of Medicine.
Dr. Kolterman holds a doctorate degree from Stanford University School of Medicine.
Postes actifs de Orville G. Kolterman
| Sociétés | Poste | Début |
|---|---|---|
National Institute of Diabetes & Digestive & Kidney Diseases
National Institute of Diabetes & Digestive & Kidney Diseases General GovernmentGovernment Engages in clinical research on serious diseases | Corporate Officer/Principal | - |
GlySens, Inc.
GlySens, Inc. Medical SpecialtiesHealth Technology Develops glucose monitoring system | Directeur/Membre du Conseil | 27/10/2011 |
American Diabetes Association Research Foundation, Inc. | Directeur/Membre du Conseil | 27/10/2011 |
Anciens postes connus de Orville G. Kolterman
| Sociétés | Poste | Fin |
|---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Directeur/Membre du Conseil | 29/01/2019 |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1992 |
The University of Colorado School of Medicine
The University of Colorado School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1983 |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | President | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Directeur Technique/Scientifique/R&D | - |
Formation de Orville G. Kolterman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Commercial Services |
National Institute of Diabetes & Digestive & Kidney Diseases
National Institute of Diabetes & Digestive & Kidney Diseases General GovernmentGovernment Engages in clinical research on serious diseases | Government |
American Diabetes Association Research Foundation, Inc. | |
GlySens, Inc.
GlySens, Inc. Medical SpecialtiesHealth Technology Develops glucose monitoring system | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado School of Medicine
The University of Colorado School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















